Psychological Ressources, Anxiodepressive Symptoms, Well-being and Therapeutical Observance in Parkinson's Disease

Parkinson's Disease Clinical Trial

— ResPsyPark  

Official title:

Psychological Ressources as a Protective Factor for Anxiety-depression, Well-being and Therapeutical Observance in Parkinson's Disease.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05919628
• Other study ID #: 2023PI077
• Status: Completed
• Start date: June 15, 2023
• Est. completion date: June 30, 2023

Study information

• Verified date: September 2023
• Source: Central Hospital, Nancy, France
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Anxiodepressive symptoms are frequently observed in Parkinson's disease patients. These non motor psychiatric charateristics of the disease negatively impairs quality of life, and may impair well-being or therapeutical observance.

The objective of this study is to determine if psychological ressources are associated to anxiodepressive symptoms, to parkinson well-being and therapeutical observance. It will be interesting to determine if the presence of some - or multiple- psychological ressources could prevent patients from anxiety, depression, impaired well-being and impaired observance.

This study will analyse retrospectively psychological scalescompleted by 30 parkinson's disease patients through previous psychological interviews. The scales investigate anxiety, depression, well-being, psychological ressources, and therapeutical observance.

The results will highlight the importance of working on psychological ressources with Parkinson's disease patients through psychotherapy, in order to improve their well-being, positive emotions and maybe contribute to better therapeutical observance.

Description:

The scales used are :

• The SPANE

• The PAS

• The LOT-R

• The SCS

• The brief BDI

• The SSAM

• The HAD

• The MAAS

• An observance scale

Recruitment information / eligibility

• Status: Completed
• Enrollment: 25
• Est. completion date: June 30, 2023
• Est. primary completion date: June 15, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients with diagnosis of Parkinson's disease

Exclusion Criteria:

• Patients with any other parkinsonian syndrome

Related Conditions & MeSH terms

• Parkinson Disease
• Parkinson's Disease

Intervention

Other:
• ResPsyPark group
Evaluation of the parkinson's disease patient's score over different psychological questionnaires and a therapeutical observance questionnaire

Locations

Country	Name	City	State
France	CHU de Nancy	Nancy

Sponsors (1)

Lead Sponsor	Collaborator
Central Hospital, Nancy, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Study of the links between psychological ressources and anxiodepressive symptoms	Correlation and regression analysis between scores at the scales evaluating anxiety (PAS, HAD) and depression (BDI, HAD), and scores at the scales evaluating psychological ressources (LOT-R, SCS, SSAm, MAAS).	At baseline
Secondary	Study of the links between therapeutical observance and anxiodepressive symptoms	Correlation and regression analysis between scores at the scales evaluating anxiety (PAS, HAD) and depression (BDI, HAD), and score at the scale evaluating therapeutical observance (%).	At baseline